- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/47 - Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
Patent holdings for IPC class A61K 38/47
Total number of patents in this class: 1971
10-year publication summary
|
161
|
138
|
171
|
173
|
194
|
200
|
207
|
244
|
179
|
59
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Halozyme, Inc. | 120 |
73 |
| Amicus Therapeutics, Inc. | 341 |
58 |
| Translate bio, Inc. | 394 |
37 |
| The Regents of the University of California | 18943 |
34 |
| Novozymes A/S | 3314 |
33 |
| Curemark, LLC | 78 |
33 |
| Takeda Pharmaceutical Company Limited | 2961 |
32 |
| DSM IP Assets B.V. | 5856 |
28 |
| Duke University | 2872 |
27 |
| ContraFect Corporation | 91 |
27 |
| Genzyme Corporation | 1205 |
26 |
| The Trustees of the University of Pennsylvania | 4122 |
25 |
| Janssen Biotech, Inc. | 1347 |
23 |
| Ansun Biopharma, Inc. | 56 |
21 |
| The Rockefeller University | 562 |
18 |
| Palleon Pharmaceuticals Inc. | 39 |
17 |
| BioMarin Pharmaceutical Inc. | 368 |
16 |
| Massachusetts Institute of Technology | 9795 |
15 |
| REGENXBIO Inc. | 232 |
15 |
| Codexis, Inc. | 776 |
14 |
| Other owners | 1399 |